Celyad Oncology SA logo
Celyad Oncology SA CYAD

Geschäftsbericht 2022
hinzugefügt 21.12.2024

report update icon

Celyad Oncology SA Langfristiger Schuldenstrom 2011-2026 | CYAD

Langfristiger Schuldenstrom Jährlich Celyad Oncology SA

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
137 K 902 K 1.08 M 1.17 M 484 K - - - - - - -

Alle Zahlen in EUR-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
1.17 M 137 K 753 K

Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler

Name Langfristiger Schuldenstrom Preis % 24h Marktkapitalisierung Land
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Amgen Amgen
AMGN
135 M $ 349.36 2.75 % $ 188 B usaUSA
AlloVir AlloVir
ALVR
316 K - 4.14 % $ 49.1 M usaUSA
Amneal Pharmaceuticals Amneal Pharmaceuticals
AMRX
6.76 M $ 12.67 2.82 % $ 3.97 B usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Applied Therapeutics Applied Therapeutics
APLT
429 K - - $ 8.42 M usaUSA
argenx SE argenx SE
ARGX
10.8 M $ 784.45 2.48 % $ 25 B niderlandNiderland
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Arcutis Biotherapeutics Arcutis Biotherapeutics
ARQT
294 K $ 24.45 5.07 % $ 3.11 B usaUSA
AVROBIO AVROBIO
AVRO
878 K - 1083.1 % $ 745 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
AstraZeneca PLC AstraZeneca PLC
AZN
382 M - - $ 96.9 B britainBritain
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
4.56 M $ 1.47 8.17 % $ 391 M britainBritain
BeiGene, Ltd. BeiGene, Ltd.
BGNE
20.7 M - 0.49 % $ 251 B cayman-islandsCayman-islands
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.83 1.86 % $ 9.21 B australiaAustralia
BioNTech SE BioNTech SE
BNTX
45 M $ 91.3 1.87 % $ 27.2 B germanyGermany
CymaBay Therapeutics CymaBay Therapeutics
CBAY
7 K - - $ 3.45 B usaUSA
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.72 5.84 % $ 17.1 M usaUSA
Avid Bioservices Avid Bioservices
CDMO
1.35 M - - $ 789 M usaUSA
Cidara Therapeutics Cidara Therapeutics
CDTX
1.38 M - - $ 1.41 B usaUSA
Cabaletta Bio Cabaletta Bio
CABA
3.46 M $ 3.07 - $ 308 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
43 K $ 3.08 1.65 % $ 6.7 B israelIsrael
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 1.93 4.89 % $ 368 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
181 K - -10.17 % $ 12.2 K usaUSA
Concert Pharmaceuticals Concert Pharmaceuticals
CNCE
1.16 M - - $ 401 M usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
CTI BioPharma Corp. CTI BioPharma Corp.
CTIC
781 K - - $ 1.2 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
554 K - 1.93 % $ 17.4 M usaUSA
Aptose Biosciences Aptose Biosciences
APTO
193 K - -45.71 % $ 1.2 M canadaCanada
Cellectar Biosciences Cellectar Biosciences
CLRB
100 K $ 2.82 2.55 % $ 7.36 M usaUSA
Deciphera Pharmaceuticals Deciphera Pharmaceuticals
DCPH
3.5 M - - $ 2.18 B usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
4.18 M - - $ 2.02 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
3.47 M - - $ 867 M germanyGermany
Cyclerion Therapeutics Cyclerion Therapeutics
CYCN
3.29 M $ 3.47 -0.29 % $ 8.74 M usaUSA